|1.||Polonelli, Luciano: 2 articles (04/2006 - 05/2002)|
|2.||Conti, Stefania: 2 articles (04/2006 - 05/2002)|
|3.||Magliani, Walter: 2 articles (04/2006 - 05/2002)|
|4.||Cassone, Antonio: 1 article (04/2006)|
|5.||Pilotti, Elisabetta: 1 article (04/2006)|
|6.||Balestra, Emanuela: 1 article (04/2006)|
|7.||Perno, Carlo Federico: 1 article (04/2006)|
|8.||Polverini, Eugenia: 1 article (04/2006)|
|9.||Casoli, Claudio: 1 article (04/2006)|
|10.||Spreca, Antonio: 1 article (05/2002)|
03/15/1994 - "To this aim, a murine mAb (KT4, IgG1) neutralizing in vitro the anti-Candida activity of a yeast killer toxin (YKT) was used as an Id vaccine to elicit Abs with toxin-like activity in a rat vaginitis model. "
03/15/1994 - "Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies."
|3.||Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
|4.||Acquired Immunodeficiency Syndrome (AIDS)
04/24/2006 - "To verify whether a synthetic therapeutic killer decapeptide (KP), a functional mimotope of a yeast killer toxin with wide-spectrum microbicidal activity, inclusive of AIDS-related opportunistic micro-organisms, through interaction with beta-glucan receptors, which has been found to possess sequence homology with critical segments in gp160 V1/V2 and V3 loops, may also be inhibiting HIV-1 replication. "
|2.||Immunoglobulin G (IgG)